Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B; MULTINEKA Study Group.

Clin Infect Dis. 2009 Sep 15;49(6):892-900. doi: 10.1086/605440.

PMID:
19663689
2.

The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.

Nolan D, Mallal S.

J HIV Ther. 2004 May;9(2):34-40. Review.

PMID:
15238874
4.

An introduction to nucleoside and nucleotide analogues.

Squires KE.

Antivir Ther. 2001;6 Suppl 3:1-14. Review.

PMID:
11678469
5.

Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV.

J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S85-90. Review.

PMID:
14562863
6.

Simplification of antiretroviral treatment--how to sustain success, reduce toxicity and ensure adherence avoiding PI use.

Barreiro P, García-Benayas T, Soriano V, Gallant J.

AIDS Rev. 2002 Oct-Dec;4(4):233-41. Review.

PMID:
12555697
7.

[Tenofovir as a strategy to avoid or limit adverse effects].

Portilla J.

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:19-24. Review. Spanish.

PMID:
19195434
8.

Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection.

Kaplan SS, Hicks CB.

J Antimicrob Chemother. 2005 Aug;56(2):273-6. Epub 2005 Jun 30. Review.

PMID:
15994247
9.

Antiretroviral-therapy-associated lipoatrophy: current status and future directions.

Nolan D, Mallal S.

Sex Health. 2005;2(3):153-63. Review.

PMID:
16335543
10.
11.

[Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques].

Sergerie M, Martinet S, Kiffer N, Teulé R, Pasquier C, Bujan L.

Gynecol Obstet Fertil. 2004 Oct;32(10):841-9. Review. French.

PMID:
15501159
12.

HIV and mitochondrial toxicity in children.

Foster C, Lyall H.

J Antimicrob Chemother. 2008 Jan;61(1):8-12. Epub 2007 Nov 13. Review.

PMID:
17999978
13.

Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: a meta-analysis of randomized controlled trials.

Ena J, Leach A, Nguyen P.

HIV Med. 2008 Oct;9(9):747-56. doi: 10.1111/j.1468-1293.2008.00627.x. Epub 2008 Jul 21. Review.

15.

Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy.

Lewis W.

Prog Cardiovasc Dis. 2003 Jan-Feb;45(4):305-18. Review.

PMID:
12638094
16.

[Lopinavir/ritonavir monotherapy as a simplification strategy in the treatment of HIV-1 infection].

Pulido Ortega F, Llenas-García J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:12-20. Review. Spanish.

PMID:
19572439
17.

Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.

Feeney ER, Mallon PW.

Curr Pharm Des. 2010 Oct;16(30):3339-51. Review.

PMID:
20687890
18.

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. doi: 10.1097/QAD.0b013e32831c54e5. Review.

PMID:
19114854
19.

The role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy.

Pérez-Molina JA, Domingo P, Martínez E, Moreno S.

J Antimicrob Chemother. 2008 Aug;62(2):234-45. doi: 10.1093/jac/dkn191. Epub 2008 May 14. Review.

PMID:
18480167
20.

Switching strategies to improve lipid profile and morphologic changes.

Barragan P, Fisac C, Podzamczer D.

AIDS Rev. 2006 Oct-Dec;8(4):191-203. Review.

PMID:
17219734

Supplemental Content

Support Center